Merja Särkioja
- Genetics top 5%
- Molecular Biology
- Oncology top 10%
- Biotechnology top 5%
- Infectious Diseases
- Co-authors
- Anna KanervaAkseli HemminkiMari RakiTuuli RankiTanja HakkarainenRenée A. DesmondLotta KangasniemiAri Ristimäki
- Topics
- Virus-based gene therapy research (17 papers)CAR-T cell therapy research (11 papers)Viral Infectious Diseases and Gene Expression in Insects (9 papers)
- Cited by
- GeneticsBiotechnologyOncology
- Partner nations
- FinlandUnited StatesGermany
In The Last Decade
Merja Särkioja
18 papers receiving 606 citations
Peers
Comparison fields: 5 of 43
- Genetics 530
- Molecular Biology 413
- Oncology 366
- Biotechnology 142
- Infectious Diseases 68
Countries citing papers authored by Merja Särkioja
This map shows the geographic impact of Merja Särkioja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merja Särkioja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merja Särkioja more than expected).
Fields of papers citing papers by Merja Särkioja
This network shows the impact of papers produced by Merja Särkioja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merja Särkioja. The network helps show where Merja Särkioja may publish in the future.
Co-authorship network of co-authors of Merja Särkioja
This figure shows the co-authorship network connecting the top 25 collaborators of Merja Särkioja. A scholar is included among the top collaborators of Merja Särkioja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Merja Särkioja. Merja Särkioja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 28 | |
| 3 | 26 | |
| 4 | 2 | |
| 5 | 31 | |
| 6 | 2 | |
| 7 | 35 | |
| 8 | 34 | |
| 9 | 36 | |
| 10 | 27 | |
| 11 | 117 | |
| 12 | 40 | |
| 13 | 34 | |
| 14 | 23 | |
| 15 | 29 | |
| 16 | 42 | |
| 17 | 36 | |
| 18 | 68 |
About Merja Särkioja
Merja Särkioja is a scholar working on Genetics, Biotechnology and Oncology, having authored 18 papers that have together received 619 indexed citations. Recurring topics across this work include Virus-based gene therapy research (17 papers), CAR-T cell therapy research (11 papers) and Viral Infectious Diseases and Gene Expression in Insects (9 papers). The work is most often cited by research in Genetics (530 citations), Biotechnology (142 citations) and Oncology (366 citations). Merja Särkioja has collaborated with scholars based in Finland, United States and Germany. Frequent co-authors include Anna Kanerva, Akseli Hemminki, Mari Raki, Tuuli Ranki, Tanja Hakkarainen, Renée A. Desmond, Lotta Kangasniemi, Ari Ristimäki, R A Desmond and Timo Ylikomi. Their work appears in journals such as Cancer, Clinical Cancer Research and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.